Formation Bio raised $600 million to expand its hub-and-spoke financing model without issuing parent equity, aiming to broaden pipeline buildout. The structure is designed to bring capital to institutions that typically invest through funds, signaling continued appetite for platform-style biotech financing tied to early-stage R&D productivity.